Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Exclusive-Cigna Drops Coverage Of GLP-1 Obesity Drugs for Its Own Employees

Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee ⁠health plan effective July 1,...

SGLT2 Inhibitors Cut Kidney Events in Nephrotic Proteinuria

In adults with type 2 diabetes and nephrotic-range proteinuria, SGLT2 inhibitors are linked to lower risks for major adverse kidney events and all-cause mortality than DPP-4 inhibitors.

How Cannabis Compounds May Help Create Weight-Loss Drugs

A new study in mice finds that cannabis extracts improve glucose regulation by improving communication between fat cells and the pancreas.

Phase 3: Rapid Relief in Thyroid Eye Disease With Veligrotug

A five-infusion course of veligrotug is well tolerated and results in rapid improvements in diplopia, proptosis, and disease activity in patients with thyroid eye disease, a phase 3 trial shows.

Gestational Diabetes May Raise Future Retinopathy Risk

In women with diabetes, a history of gestational diabetes is associated with a higher risk for diabetic retinopathy, with risk increasing as gestational diabetes severity increases.

BMI at Age 6 Predicts Obesity Risk in Young Adulthood

BMI at age 6 strongly predicts the risk for overweight and obesity in young adulthood; children with a high BMI and slower growth between ages 2 and 6 have odds similar to peers with an average BMI.

Todays Updates

Medline Draws Another US FDA Warning in Two Months Over Quality Lapses

The U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, the ⁠second such action against the company in two...

Masson Tumor in a Young Woman Mimicking Angiosarcoma

An intramuscular Masson tumor in the deltoid muscle mimics a malignant vascular tumor on imaging, making surgical excision and histopathologic diagnosis essential.

Healthcare Strikes Ethical in Few Cases: Ethicist

Ethicist Art Caplan discusses the ethics of healthcare strikes for patients and workers.

Is Alcohol Part of a Healthy Lifestyle?

Cardiologist Chris Labos takes a look at the French paradox and the J-shaped curve — which tout moderate alcohol as healthy — and asks is the amount of alcohol you should drink really zero?

S3 Episode 4: Investigator-Initiated Clinical Trials in Endometrial Cancer

Drs Ursula A. Matulonis and Stephanie Lheureux discuss the importance of investigator-initiated clinical trials in endometrial cancer, research on carcinosarcoma, and ctDNA.

Wearable Ultrasound Patch Does Continuous Fetal Monitoring

A skin-mounted ultrasound patch tracks fetal blood flow in real time and may help detect complications in high-risk pregnancies earlier than intermittent scans.

Spinal Cord Treatment Triggers Hope and Lawsuits in Brazil

An experimental treatment for spinal cord injuries is drawing patients from as far as Mexico, mobilizing the government to expedite approval before its safety has been proven in a clinical trial.

Todays Updates

Medline Draws Another US FDA Warning in Two Months Over Quality Lapses

The U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, the ⁠second such action against the company in two...

Masson Tumor in a Young Woman Mimicking Angiosarcoma

An intramuscular Masson tumor in the deltoid muscle mimics a malignant vascular tumor on imaging, making surgical excision and histopathologic diagnosis essential.

Healthcare Strikes Ethical in Few Cases: Ethicist

Ethicist Art Caplan discusses the ethics of healthcare strikes for patients and workers.

Is Alcohol Part of a Healthy Lifestyle?

Cardiologist Chris Labos takes a look at the French paradox and the J-shaped curve — which tout moderate alcohol as healthy — and asks is the amount of alcohol you should drink really zero?

S3 Episode 4: Investigator-Initiated Clinical Trials in Endometrial Cancer

Drs Ursula A. Matulonis and Stephanie Lheureux discuss the importance of investigator-initiated clinical trials in endometrial cancer, research on carcinosarcoma, and ctDNA.

Wearable Ultrasound Patch Does Continuous Fetal Monitoring

A skin-mounted ultrasound patch tracks fetal blood flow in real time and may help detect complications in high-risk pregnancies earlier than intermittent scans.

Spinal Cord Treatment Triggers Hope and Lawsuits in Brazil

An experimental treatment for spinal cord injuries is drawing patients from as far as Mexico, mobilizing the government to expedite approval before its safety has been proven in a clinical trial.

Latest News

Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee ⁠health plan effective July 1,...

In adults with type 2 diabetes and nephrotic-range proteinuria, SGLT2 inhibitors are linked to lower risks for major adverse kidney events and all-cause mortality than DPP-4 inhibitors.

A new study in mice finds that cannabis extracts improve glucose regulation by improving communication between fat cells and the pancreas.

A five-infusion course of veligrotug is well tolerated and results in rapid improvements in diplopia, proptosis, and disease activity in patients with thyroid eye disease, a phase 3 trial shows.

In women with diabetes, a history of gestational diabetes is associated with a higher risk for diabetic retinopathy, with risk increasing as gestational diabetes severity increases.

BMI at age 6 strongly predicts the risk for overweight and obesity in young adulthood; children with a high BMI and slower growth between ages 2 and 6 have odds similar to peers with an average BMI.

News All Time

Continuous Glucose Monitoring: Is It Time to Expand Use?

Growing evidence suggests that continuous glucose monitoring improves glycemic control, treatment decisions, and patient engagement in people with type 2 diabetes.

Time-Restricted Eating Reshapes Gut Flora, Aids Weight Loss

Time-restricted eating alters the gut microbiota and serum metabolite profiles in young adults with overweight or obesity, with changes linked to weight loss and improved cardiometabolic health.

Tirzepatide Raises Thyroid Risk in Certain At-Risk Patients

Patients with end-stage renal disease or preexisting thyroid disease are more likely to experience either a new thyroid problem or a worsening of their thyroid disease while on tirzepatide.

Is It Time to Talk to Patients About Bowel Hygiene?

Advising patients about bowel hygiene is on the rise as understanding grows about the multifaceted nature of GI disorders.

France Becomes First EU Country to Reimburse Anti-obesity Drugs, Minister Says

France will reimburse the cost of weight-loss drugs prescribed to severely obese patients from mid-June in a ⁠first for a European Union country, Health Minister Stephanie...

Use of Common Food Colours Tied to High Type 2 Diabetes Risk

A higher intake of several food colouring additives is associated with an increased risk of developing type 2 diabetes, an analysis of the French NutriNet-Santé cohort shows.

CVS Brings Back Coverage for Lilly's Obesity Drug Zepbound

CVS Health will restore Eli Lilly's weight-loss injection Zepbound to its list of covered drugs and add the drugmaker's newly approved obesity pill, Foundayo, ⁠it said on...

PFAS Linked to Lower Bone Density in Youth

Data from the long-running HOME study links higher exposure to certain polyfluoroalkyl substances ‘forever chemicals’ with lower bone mineral density in children and adolescents.

Indigenous-Led Study Targets Transplant Inequities

Researchers will document patient experiences and barriers to care across British Columbia, Alberta, and Saskatchewan.

Weight-Loss Pill Approval Highlights Important Role of PCPs

FDA approval of Eli Lilly’s weight-loss pill on April 1 shows the fast-changing landscape for weight loss, obesity medications.

Thyroid Aging Patterns Can Predict Mortality Risk

Thyroid function changes modestly with age but shows greater variability from age 65 years onward, and distinct patterns of thyroid function change are linked to an increased risk for mortality.

EMA Panel Backs Weekly Hormone for Child Growth Disorders

European regulators recommend expanding once-weekly growth hormone therapy to include children born small for gestational age and those with Noonan syndrome, potentially reducing injection burden.

Curcumin Supplementation May Help Ease Depression

Curcumin, the primary active compound in the spice turmeric, was associated with significant reduction in depressive symptoms in new research that has been characterized as ‘clinically meaningful.’

Dexcom Warns Patients as Stolen Glucose Sensors Hit the Market

Medical device maker Dexcom said on Tuesday some of its glucose ⁠sensors slated for destruction were instead stolen and sold, prompting the company ⁠to warn users not to use...

Europe Moves Closer to New Retinal Disease Biosimilar

A new anti-VEGF biosimilar has moved closer to European approval for several vision-threatening retinal diseases, including choroidal neovascularization.

Weight Loss Alone May Not Prevent T2D in Some Patients

Prediabetes management often emphasizes weight loss, but a long-term follow-up study found that for some older adults, thinner isn’t always better.

Recommended News For You

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

According to a study, breast cancer cells work together to physically breach barriers and proliferate.

Oncologist on Hantavirus Cruise; Bile Duct Cancer Drug OK'd; Untreated Lung Cancers

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.

healthy despite having advanced cancer.

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

Studies point to redlining as a 'perfect storm' for breast cancer

Recommended Articles For You

The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure  

Revolutionizing Cancer Care with Fulphila: A New Hope for Patients 

Uncovering the Role of Pap Smear in Oncology: A New Frontier in Cancer Detection 

The Immune Revolution: Neoantigen Vaccines and the Dawn of Personalized Cancer Therapy in 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

fresh E. Coli Outbreak: ECMO Redefining Death and Bringing Universal Blood One Step Nearer.

2.

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

3.

Even when they are not paying attention, children are still learning.

4.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

5.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

1.

The Benefits and Side Effects of Bortezomib in the Fight Against Cancer 

2.

Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control

3.

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments

4.

A Visual Guide to Understanding Breast Cancer Staging

5.

A Closer Look at MCV Modules: Features, Functions, and Benefits 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

3.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

4.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot